The European Central Bank (ECB) decided to keep its key interest rate steady at 2.5%, following a 25 basis point increase in September, despite inflation in the euro zone rising to 3.8%, the highest since September 2023. The ECB cited rising energy prices as a risk to inflation and growth, with energy inflation reaching 18.8% due to Middle East tensions. Financial conditions have tightened, which may slow inflation and growth. The ECB's future policy is uncertain, especially with President Christine Lagarde announcing her departure; one more rate hike to 2.75% is expected in December before the hiking cycle ends.
The European Central Bank's decision to hold its key interest rate at 2.5% provides context for financial markets. For readers following the Financials sector, 102 of 142 US stocks traded on Pluang rose today. Notable movers include CleanSpark Inc at USD 8.23 with a 4.02% decline, Hut 8 Corp at USD 66.67 down 4.02%, and Riot Platforms Inc at USD 13.88 down 3.91%, as of Oct 29, 2026 20:12 WIB.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
